Articles 7 Questions: Jörg Land on the first reimbursed mobile app in... Jörg Land talks about the approval process for a new app technology for treating tinnitus, the first ever to be reimbursed in Germany
News ESC26: Can Arrowhead pierce Ionis' triglyceride armour? Arrowhead Pharma is squaring up to rival Ionis in the severe hypertriglyceridaemia (sHTG) market, drawing on phase 3 data at ESC 2026.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.